Articles and Blogs

The Gap Between FDA Authorization and Medicare Coverage In April 2026, the Centers for Medicare & Medicaid Services (“CMS”) and the U.S. Food and Drug Administration (“FDA”) announced a proposed initiative, the Regulatory Alignment for Predictable and Immediate Device (“RAPID”) pathway, intended to expedite Medicare coverage of certain Class II and Class III devices... READ MORE